HDGFL2 and malaria: This benchmarking protocol was applied to two WHO-prequalified RDTs as well as two RDTs produced by Rapigen: one RDT for Pf, BIOCREDIT Malaria Ag Pf (pLDH/HRPII) with test lines to detect HRP2 and PfLDH; and one for Pf and Pv, the BIOCREDIT Malaria Ag Pf/Pv (pLDH/pLDH) with test lines to detect PfLDH and PvLDH.